EU and US could reach trade deal this weekend - Reuters
In a recent transaction, Dawn Christine Maroney, President of Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 30,000 shares of the company’s common stock. The shares were sold at a weighted-average price of $13.7157, resulting in a total transaction value of approximately $411,471. The transaction comes as ALHC shows remarkable momentum, with the stock up 107% over the past year and 66% in the last six months. According to InvestingPro analysis, the stock is currently trading near its Fair Value. This sale was executed under a pre-arranged Rule 10b5-1 trading plan, which was adopted on March 13, 2024. Following this transaction, Maroney retains ownership of 1,576,097 shares of Alignment Healthcare. The shares were sold in multiple transactions, with prices ranging from $13.56 to $13.95 per share. With a market capitalization of $2.7 billion and revenue growth of 43% in the last twelve months, InvestingPro subscribers can access 8 additional key insights about ALHC’s financial health and growth prospects through the comprehensive Pro Research Report.
In other recent news, Alignment Healthcare has reported a 35% year-on-year increase in health plan membership, reaching approximately 209,900 as of January 1. This growth is part of the company’s strategy to expand its Medicare Advantage offerings, with projections indicating membership could rise to between 225,000 and 231,000 by the end of 2025. The company has also reaffirmed its full-year guidance ranges for 2024, showing confidence in its financial forecasts. Stifel analysts have taken note of these developments, raising Alignment Healthcare’s price target from $14.00 to $16.00 while maintaining a Buy rating. The analysts highlighted the company’s strong Annual Enrollment Period results and its strategic positioning in the market. Alignment Healthcare’s technology-driven approach has allowed it to outperform competitors, capturing market share in a challenging post-pandemic environment. Analysts at Stifel believe that the company’s performance will continue to benefit from favorable conditions, including changes in star rating mechanics and the last year of the V28 initiative. These factors contribute to a positive outlook for Alignment Healthcare over the next few years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.